Skip to main content
Amylyx Pharmaceuticals, Inc. (AMLX)
NASDAQ: AMLX · IEX Real-Time Price · USD
1.740
-0.140 (-7.45%)
At close: Jul 2, 2024, 4:00 PM
1.750
+0.010 (0.57%)
After-hours: Jul 2, 2024, 7:51 PM EDT

Amylyx Pharmaceuticals Revenue

Amylyx Pharmaceuticals had revenue of $398.00M in the twelve months ending March 31, 2024, with 324.95% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $88.64M with 24.10% year-over-year growth. In the year 2023, Amylyx Pharmaceuticals had annual revenue of $380.79M with 1,612.94% growth.

Revenue (ttm)
$398.00M
Revenue Growth
+324.95%
P/S Ratio
0.30
Revenue / Employee
$1,036,461
Employees
384
Market Cap
118.33M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023380.79M358.56M1,612.94%
Dec 31, 202222.23M21.95M7,700.00%
Dec 31, 2021285.00K-365.00K-56.15%
Dec 31, 2020650.00K-776.00K-54.42%
Dec 31, 20191.43M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

AMLX News

More News